Rashtriya Newsflash

Pharmacovigilance and Drug Safety Software Market Overview

According to Mordor Intelligence, the pharmacovigilance and drug safety software market size in 2026 is estimated at USD 234.73 million, growing from USD 222.18 million in 2025 and projected to reach USD 309.03 million by 2031, registering a CAGR of 5.65% during the forecast period.

This pharmacovigilance and drug safety software industry expansion is supported by the growing shift from traditional compliance tools to more responsive systems that can handle real-time safety data. Companies are increasingly investing in platforms that simplify adverse event reporting, automate workflows, and improve visibility across global operations. These factors are contributing to overall pharmacovigilance and drug safety software market growth.

Pharmacovigilance and Drug Safety Software Market Drivers

Growing Use of AI in Case Processing

One of the key pharmacovigilance and drug safety software market trends is the integration of AI-driven tools for case intake and triage. These systems help reduce manual workloads by identifying duplicate cases, prioritizing critical events, and supporting faster decision-making. This shift is improving efficiency and contributing to pharmacovigilance and drug safety software market growth.

Increased Adoption of Cloud-Based Platforms

Cloud deployment has become a preferred choice in the pharmacovigilance and drug safety software industry. Organizations are moving away from legacy systems toward cloud-based platforms that allow easier updates, better scalability, and remote accessibility. This trend is also helping companies manage global safety data more effectively, improving pharmacovigilance and drug safety software market size expansion.

Alignment with Global Regulatory Standards

Regulatory harmonization continues to influence pharmacovigilance and drug safety software market trends. Standardized formats for safety reporting are encouraging organizations to adopt software solutions that can support multiple regulatory frameworks. This is driving demand for flexible and compliant systems, supporting pharmacovigilance and drug safety software market growth.

Expansion of Clinical Trials in Emerging Regions

The relocation of clinical trials to regions such as Asia Pacific is creating new demand for safety monitoring tools. Faster approvals and operational advantages are encouraging sponsors to invest in advanced pharmacovigilance systems. This regional shift is strengthening pharmacovigilance and drug safety software market share across emerging markets.

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/pharmacovigilance-and-drug-safety-software-market?utm_source=abnewswire

Pharmacovigilance and Drug Safety Software Market Segmentation

By Functionality

• Adverse Event Reporting Software

• Drug Safety Audit Software

• Issue Tracking Software

• Fully Integrated Safety Suites

• Signal Detection and Risk-Management Tools

By Mode of Delivery

• On-premise

• Cloud / SaaS

• Hybrid Deployment

By End User

• Pharmaceutical and Biotechnology Companies

• Contract Research Organizations

• Business Process Outsourcing Firms

• Medical Device Manufacturers

• Other Pharmacovigilance Service Providers

By Geography

• North America

• United States

• Canada

• Mexico

• Europe

• Germany

• United Kingdom

• France

• Italy

• Spain

• Rest of Europe

• Asia Pacific

• China

• Japan

• India

• South Korea

• Australia

• Rest of Asia Pacific

• Middle East and Africa

• GCC

• South Africa

• Rest of Middle East and Africa

• South America

• Brazil

• Argentina

• Rest of South America

Pharmacovigilance and Drug Safety Software Market Key Players

The pharmacovigilance and drug safety software market share is shaped by companies focusing on compliance-focused solutions, cloud delivery models, and integrated safety platforms.

• Ennov Solutions Inc.

• Extedo GmbH

• United BioSource Corporation

• AB Cube

• ArisGlobal

Conclusion

The pharmacovigilance and drug safety software market is moving toward more connected and data-driven systems that support continuous safety monitoring. Organizations are placing greater importance on tools that can handle increasing data volumes while ensuring compliance with global standards. This shift is expected to sustain pharmacovigilance and drug safety software market growth over the coming years.

The pharmacovigilance and drug safety software market forecast indicates steady demand driven by regulatory requirements, expanding clinical activities, and the need for faster reporting systems. Cloud adoption and AI integration are likely to remain central to the pharmacovigilance and drug safety software industry, supporting improved efficiency and cost management.

Industry Related Reports:

Telemedicine Market:

The telemedicine market is projected to grow from USD 132.54 billion in 2025 to USD 317.26 billion by 2031, registering a CAGR of 15.21% during 2026–2031. Growth is driven by sustained reimbursement parity across U.S. states, rising adoption of 5G-enabled virtual care, and increasing demand from aging populations requiring remote monitoring and chronic disease management. Get more insights: https://www.mordorintelligence.com/industry-reports/global-telemedicine-market-industry?utm_source=abnewswire

Healthcare IT Market Size:

The healthcare IT market is expected to expand from USD 0.47 trillion in 2025 to USD 1.16 trillion by 2031, at a CAGR of 16.41% from 2026 to 2031. This growth is fueled by mandatory interoperability regulations, rapid cloud transformation, and the integration of AI into clinical workflows, alongside rising cybersecurity investments and digital health initiatives. Get more insights: https://www.mordorintelligence.com/industry-reports/global-healthcare-it-market-industry?utm_source=abnewswire

Pharmacovigilance Market Share:

The pharmacovigilance market is estimated to grow from USD 10.45 billion in 2026 to USD 18.26 billion by 2031, at a CAGR of 11.78%. Expansion is supported by increasing drug development pipelines, stricter regulatory requirements for post-marketing surveillance, and growing adoption of AI-driven safety monitoring solutions, especially through outsourcing to CROs. Get more insights: https://www.mordorintelligence.com/industry-reports/pharmacovigilance-pv-market?utm_source=abnewswire

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

[email protected] https://www.mordorintelligence.com/

Media Contact
Company Name: Mordor Intelligence Private Limited
Contact Person: Jignesh Thakkar
Email: Send Email
Phone: +1 617-765-2493
Address:11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli
City: Hyderabad
State: Telangana 500008
Country: India
Website: https://www.mordorintelligence.com/